Pathogenesis and clinical significance of dermatophytes: A comprehensive review
Journal Title: Innovations in Pharmaceuticals and Pharmacotherapy (IPP) - Year 2017, Vol 5, Issue 1
Abstract
Dermatophytes, a group of keratinophilic fungi thriving on the keratin substrate are the etiological agents responsible for causing cutaneous infections. Dermatophytosis currently treated with the commercially available topical and oral antifungal agents in spite of the existing side effects. Treatment of these cutaneous infections with secondary metabolites produced by marine microorganisms considered as a novel approach. For many years, these organisms explored with the view of developing antibacterial, antifungal, antiviral, anticancer and antiparasitic drugs. Exploring the unexplored aspect of actinobacteria for developing anti-dermatophytic drugs is a novel attempt, which needs further investigation. The prevalence of superficial mycotic infection worldwide is 20–25% of which dermatophytes are the most common agents. Recent developments in understanding the path physiology of dermatophytosis have confirmed the central role of cell-mediated immunity in countering these infections. Hence, a lack of delayed hypersensitivity reaction in presence of a positive immediate hypersensitivity (IH) response to trichophytin antigen points toward the chronicity of disease. Diagnosis, though essentially clinical should be confirmed by laboratory-based investigations. Several new techniques such as polymerase chain reaction (PCR) and mass spectroscopy can help to identify the different dermatophyte strains. Management involves the use of topical antifungal in limited disease, and oral therapy is usually reserved for more extensive cases. The last few years have seen a significant rise in the incidence of chronic dermatophyte infections of skin which have proven difficult to treat. However, due to the lack of updated national or international guidelines on the management of tinea corporis, cruris, and pedis, treatment with systemic antifungal is often empirical. The present review aims to revisit this important topic and will detail the pathogenesis and clinical significance of Dermatophytes: tinea corporis, tinea cruris, and tinea pedia while highlighting the lack of clarity of certain management issues.
Authors and Affiliations
Suganth M
Keywords
Related Articles
- EP ID EP569426
- DOI -
- Views 68
- Downloads 0
Development of non-covalent derivative of sulfasalazine with theobromine for its properties optimization
To customize the biopharmaceutical parameters of a poorly soluble, disease modifying anti-rheumatic drug, sulfasalazine (SSZ) by preparing its novel non-covalent derivative (NCD). For this theobromine (TBR) was used as c...
Antibiotic susceptibility pattern of enterococcal isolates from a tertiary care hospital
Enterococci have been regarded as pathogens that seldom cause serious infections. However, in the last decade they have emerged as an important cause of nosocomial infections, with an increasing frequency of multidrug re...
Electrochemotherapy: An enhancement of cytotoxicity of anticancer drugs
Electrochemotherapy (ECT) is a local treatment of cancer employing electric pulses to improve transmembrane transfer of cytotoxic drugs. In this article, we discuss ECT and review the steps needed to move such a treatmen...
Mycobacterium tuberculosis has affinity of frequent mutation in the codon sequence 530-533 of mutation type serine 531 leucine
As long as MDR-TB verified, use of inadequate and hence ineffective antibiotics may lead to further spread of resistant bacteria and amplification of resistance. Therefore, rapid diagnosis and identification of MDR-TB is...
Transdermal drug delivery by iontophoresis: Mechanistic aspects
The passive diffusion of drugs in transdermal delivery is hindered by the stratum corneum and limits the scope of deliverable molecules through the skin. The evolution of novel electrical and physical enhancement techniq...